INACTIVE HEPATITIS B CARRIER AND PREGNANCY OUTCOMES

Objective: To assess the impact of hepatitis B carrier status on pregnancy and perinatal outcome. Study Design: Cross sectional study. Place and Duration of Study: Department of Gynaecology and Obstetrics, Pakistan Naval Ship Shifa Hospital, Karachi, from Feb 2017 to Jan 2018. Methodology:...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rabiah Anwar, Kashif Razzaq
Formato: article
Lenguaje:EN
Publicado: Army Medical College Rawalpindi 2020
Materias:
R
Acceso en línea:https://doaj.org/article/e6b0f938253b4acf852bd5173ebfbe8f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Objective: To assess the impact of hepatitis B carrier status on pregnancy and perinatal outcome. Study Design: Cross sectional study. Place and Duration of Study: Department of Gynaecology and Obstetrics, Pakistan Naval Ship Shifa Hospital, Karachi, from Feb 2017 to Jan 2018. Methodology: A total of 9526 women delivered during study period. 9305 women fulfilling the inclusion criteria were included in study. Two hundred and twenty one (221) women were excluded because of not fulfilling the inclusion criteria. Out of study group, 9104 women were HBsAg negative while 201 had positive hepatitis B carrier status. Antenatal complications (such as gestational diabetes, gestational hypertension, pre eclampsia), mode of delivery (vaginal delivery, elective cesarean, emergency cesarean) and perinatal outcomes (preterm delivery, low birth weight at delivery, live birth rate, APGAR score at 1 and 5 min) were observed among hepatitis B carrier and noncarrier. Results: There was no significant difference in point prevalence of major antenatal complications, mode of delivery and perinatal outcomes in HBsAg carriers and noncarriers. A slightly higher rate of preterm birth was observed in hepatitis B carriers (4.9%) as compared to noncarriers (2.6%). Conclusion: Hepatitis B carriers have slightly increased risk of preterm delivery.